NCT02170012View on ClinicalTrials.gov

A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Elderly
Interventions
DRUG

PF-06743649

20 mg tablet once daily dosing for 14 days

DRUG

Placebo

Placebo tablet once daily dosing for 14 days

DRUG

PF-06743649

To be decided dose, tablet once daily dosing for 14 days

DRUG

Placebo

Placebo tablet once daily dosing for 14 days

DRUG

PF-06743649

To be decided dose, tablet once daily dosing for 14 days

DRUG

Placebo

Placebo tablet once daily dosing for 14 days

DRUG

PF-06743649

To be decided dose, tablet once daily dosing for 14 days

DRUG

Placebo

Placebo tablet once daily dosing for 14 days

DRUG

PF-06743649

To be decided dose, tablet once daily dosing for 14 days

DRUG

Placebo

Placebo tablet once daily dosing for 14 days

Trial Locations (2)

33143

Miami Research Associates, Inc., South Miami

MRA Clinical Research, LLC, South Miami

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02170012 - A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649 | Biotech Hunter | Biotech Hunter